Liu et al. [43,44] built up a series of DNA nanostructures as a co-delivery vector of RNA interference (RNAi)/p53 and chemodrugs for combined therapy, to combat multidrug-resistant tumor (MCF-7R) in vitro and in vivo without apparent systemic toxicity. The gene discussed is TP53; the disease is neoplasm.